152 related articles for article (PubMed ID: 29798399)
1. [Investigation of epithelial-mesenchymal transition induced by cisplatin on human laryngeal resistant cancer cells].
Gong XR; Yu F; Zhou YB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Dec; 31(23):1839-1843. PubMed ID: 29798399
[No Abstract] [Full Text] [Related]
2. [Small interference of transcription factor Snail contribute to enhanced cisplatin sensitivity on human laryngeal resistant cancer cells].
Yu F; Gong XR; Zhou YB; Liu W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Mar; 32(5):350-354. PubMed ID: 29798292
[No Abstract] [Full Text] [Related]
3. RNA interference (RNAi) mediated stable knockdown of protein casein kinase 2-alpha (CK2α) inhibits migration and invasion and enhances cisplatin-induced apoptosis in HEp-2 laryngeal carcinoma cells.
Zhang F; Yang B; Shi S; Jiang X
Acta Histochem; 2014 Jul; 116(6):1000-6. PubMed ID: 24831064
[TBL] [Abstract][Full Text] [Related]
4. Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP).
Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
Cell Physiol Biochem; 2016; 39(3):1098-110. PubMed ID: 27562816
[TBL] [Abstract][Full Text] [Related]
5. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
7. KLF5 silence attenuates proliferation and epithelial-mesenchymal transition induction in Hep-2 cells through NF-κB signaling pathway.
Liu FF; Dong L; Yang X; Li DJ; Shen YY; Liu ZL
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3867-3875. PubMed ID: 31115014
[TBL] [Abstract][Full Text] [Related]
8. The effect of sodium butyrate and cisplatin on expression of EMT markers.
Mrkvicova A; Chmelarova M; Peterova E; Havelek R; Baranova I; Kazimirova P; Rudolf E; Rezacova M
PLoS One; 2019; 14(1):e0210889. PubMed ID: 30653577
[TBL] [Abstract][Full Text] [Related]
9. Ionizing radiation promotes advanced malignant traits in nasopharyngeal carcinoma via activation of epithelial-mesenchymal transition and the cancer stem cell phenotype.
Su Z; Li G; Liu C; Ren S; Tian Y; Liu Y; Qiu Y
Oncol Rep; 2016 Jul; 36(1):72-8. PubMed ID: 27108809
[TBL] [Abstract][Full Text] [Related]
10. A combined modality of carboplatin and photodynamic therapy suppresses epithelial-mesenchymal transition and matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in HEp-2 human laryngeal cancer cells via ROS-mediated inhibition of MEK/ERK signalling pathway.
Mao W; Sun Y; Zhang H; Cao L; Wang J; He P
Lasers Med Sci; 2016 Nov; 31(8):1697-1705. PubMed ID: 27481258
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.
Zhang P; Liu H; Xia F; Zhang QW; Zhang YY; Zhao Q; Chao ZH; Jiang ZW; Jiang CC
Int J Mol Med; 2014 Jan; 33(1):151-9. PubMed ID: 24173500
[TBL] [Abstract][Full Text] [Related]
12. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
[TBL] [Abstract][Full Text] [Related]
13. Piperlongumine inhibits TGF-β-induced epithelial-to-mesenchymal transition by modulating the expression of E-cadherin, Snail1, and Twist1.
Park MJ; Lee DE; Shim MK; Jang EH; Lee JK; Jeong SY; Kim JH
Eur J Pharmacol; 2017 Oct; 812():243-249. PubMed ID: 28734931
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway.
Wang H; Zhang G; Zhang H; Zhang F; Zhou B; Ning F; Wang HS; Cai SH; Du J
Eur J Pharmacol; 2014 Jan; 723():156-66. PubMed ID: 24333218
[TBL] [Abstract][Full Text] [Related]
15. Cx43 reverses the resistance of A549 lung adenocarcinoma cells to cisplatin by inhibiting EMT.
Yu M; Zhang C; Li L; Dong S; Zhang N; Tong X
Oncol Rep; 2014 Jun; 31(6):2751-8. PubMed ID: 24789679
[TBL] [Abstract][Full Text] [Related]
16. EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer.
Haslehurst AM; Koti M; Dharsee M; Nuin P; Evans K; Geraci J; Childs T; Chen J; Li J; Weberpals J; Davey S; Squire J; Park PC; Feilotter H
BMC Cancer; 2012 Mar; 12():91. PubMed ID: 22429801
[TBL] [Abstract][Full Text] [Related]
17. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
Zhang Y; Zhang Q; Chen H; Wang C
Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824
[TBL] [Abstract][Full Text] [Related]
18. Salinomycin reduces epithelial-mesenchymal transition-mediated multidrug resistance by modifying long noncoding RNA HOTTIP expression in gastric cancer cells.
Mao Z; Wu Y; Zhou J; Xing C
Anticancer Drugs; 2019 Oct; 30(9):892-899. PubMed ID: 30882398
[TBL] [Abstract][Full Text] [Related]
19. Ampelopsin reduces the migration and invasion of ovarian cancer cells via inhibition of epithelial-to-mesenchymal transition.
Liu T; Liu P; Ding F; Yu N; Li S; Wang S; Zhang X; Sun X; Chen Y; Wang F; Zhao Y; Li B
Oncol Rep; 2015 Feb; 33(2):861-7. PubMed ID: 25502786
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition.
Shao Q; Zhang P; Ma Y; Lu Z; Meng J; Li H; Wang X; Chen D; Zhang M; Han Y; Liu H; Ma S
Gene; 2018 Apr; 652():48-58. PubMed ID: 29427737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
